Windtree Therapeutics Inc (NAS:WINT)

$ 0.2552 -0.0137 (-5.09%) Market Cap: 2.29 Mil Enterprise Value: 2.01 Mil PE Ratio: 0 PB Ratio: 0.14 GF Score: 22/100

Windtree Therapeutics Inc Annual Shareholders Meeting Transcript
Aug 15, 2023
Windtree Therapeutics Inc R&D and Investor Day Transcript
Jun 14, 2023
Windtree Therapeutics Inc Fireside Chat Hosted By Oppenheimer Transcript
Jul 18, 2022
Windtree Therapeutics Inc to Discuss its Istaroxime Phase 2 Study Call Transcript
May 23, 2022
Windtree Therapeutics Inc at Lytham Partners Spring Investor Conference (Virtual) Transcript
Apr 04, 2022
Windtree Therapeutics Inc At KOL Webinar on Istaroxime For The Treatment Of Acute Heart Failure And The Upcoming Data In Early Cardiogenic Shock Call Transcript
Oct 19, 2021
Windtree Therapeutics Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript
Jul 13, 2021
Windtree Therapeutics Inc at Ladenburg Thalmann R&D Showcase Transcript
Dec 09, 2020
Windtree Therapeutics, Inc. - Special Call Transcript
Jun 04, 2020
Windtree Therapeutics, Inc. - Special Call Transcript
Dec 11, 2019
Windtree Therapeutics, Inc. - Special Call Transcript
Jun 25, 2019

Windtree Therapeutics, Inc. - Special Call Transcript

Dec 11, 2019 / 01:00PM GMT

Release Date Price: $9720.01

Transcript

Operator

Good day, and welcome to the Windtree Programs and Business Update Conference Call. (Operator Instructions) Please note this event is being recorded.

I would now like to turn the conference over to John Tattory, Chief Financial Officer. Please go ahead.

John A. Tattory

Windtree Therapeutics, Inc. - Senior VP, CFO & Treasurer

Thank you, Elissa. Good morning, everyone, and thanks for joining us on this morning's call to discuss our recently announced $26 million private placement, to provide updates on our acute cardiovascular and acute pulmonary clinical programs and other business initiatives.

Joining me today are Craig Fraser, our Chief Executive Officer; and Dr. Steve Simonson, our Chief Medical Officer.

Today's call is being webcast, and you can view the slides we will be presenting in the Investors section of our website at windtreetx.com. A replay of this webcast and slide presentation will be available on our website shortly after the call is completed.

Before we begin, I want to remind you that today's

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.